Press Releases

Find out the latest announcements and updates from Genialis. This is where you’ll find newest reports on our partnerships, collaborations, and achievements.

November 2, 2021|
Genialis Debuts ResponderID™ for Clinical Biomarker Discovery
October 22, 2021|
Genialis Innovates Machine Learning Solutions for Clinical Biomarker Discovery
June 17, 2021|
Genialis Expands Support for Clinical Biomarker Discovery Platform
April 12, 2021|
Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR
March 19, 2021|
Genialis, BioLab Partner to Improve Precision Medicine Using Data Mining
November 10, 2020|
Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries
January 22, 2020|
Genialis and OncXerna Collaborate on Precision Medicine Initiative in Gastric Cancer
January 8, 2020|
Genialis Advances Precision Medicine Solutions for Diseases of Unmet Need
October 31, 2019|
Easing the “Informatics Bottleneck” Burden in Next-generation Sequencing

Media Kit

Boilerplate

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.